Biohaven Pharmaceutical Holding competitive analysis

Loading summary...

Explore Biohaven Pharmaceutical Holding's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 16, 2024Use Of Riluzole Prodrugs To Treat Ataxias1

Latest publications and patents of Biohaven Pharmaceutical Holding New

Explore the latest publications and patents granted to Biohaven Pharmaceutical Holding, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biohaven Pharmaceutical Holding

Oct 16, 2024Use Of Riluzole Prodrugs To Treat AtaxiasGranted And Under Opposition

Latest PTAB cases involving Biohaven Pharmaceutical Holding

Discover the latest PTAB cases involving Biohaven Pharmaceutical Holding, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biohaven Pharmaceutical Holding with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOHAVEN PHARMACEUTICAL HOLDING - 1 - -
KRAUS & LEDERER PARTGMBB68 - - -